B12 Injection vs P21
A side-by-side research comparison of B12 Injection and P21 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | B12 Injection | P21 |
|---|---|---|
| Full name | Methylcobalamin (Vitamin B12) Injectable | P21 (CNTF-Derived Tetrapeptide) |
| Category | Cognitive & Nootropic | Cognitive & Nootropic |
| Status | Prescribed / OTC | Research compound |
| Mechanism | Cofactor for methionine synthase (DNA methylation) and methylmalonyl-CoA mutase (energy metabolism). Supports myelin synthesis, neurotransmitter production, and red blood cell formation. | Mimics CNTF neurogenesis-enhancing portion by increasing BDNF and activating PI3K/Akt. Inhibits LIF signaling to selectively promote neural stem cell proliferation. |
| Molecular weight | 1344.38 Da | ~450 Da |
| Half-life | ~6 days | 4-6 hours |
| Bioavailability | ~100% IM/SC | Moderate (crosses BBB) |
| Typical dose | 1000-5000 mcg | 50-100 mcg/kg |
| Frequency | 1-3x per week | Daily |
| Route | Intramuscular or subcutaneous injection | Intranasal or Subcutaneous |
B12 Injection reported benefits
- Increased energy
- Improved cognitive function
- Nerve repair
- Red blood cell production
- Better sleep
- Mood enhancement
P21 reported benefits
- Hippocampal neurogenesis
- BDNF increase
- Cognitive enhancement
- BBB penetrant
- No appetite suppression
- Dendritic branching
Related comparisons
Research and educational reference only. Not medical advice.